SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001842952-21-000025
Filing Date
2021-12-17
Accepted
2021-12-17 16:12:39
Documents
1
Period of Report
2021-10-22

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_163977554088927.html 4/A  
1 FORM 4/A wf-form4a_163977554088927.xml 4/A 5647
  Complete submission text file 0001842952-21-000025.txt   7144
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 267-225-7416
Context Therapeutics Inc. (Issuer) CIK: 0001842952 (see all company filings)

IRS No.: 472566423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address
Dick Evan G. (Reporting) CIK: 0001862116 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40654 | Film No.: 211501687